Subjective Cognitive Impairment: Clinical Trials

2 trials for Subjective Cognitive Impairment, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 completed. 2 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 22Active not recruiting 1, Completed 1
Phase 31Active not recruiting 1

Follow Subjective Cognitive Impairment: new trials by email Literature Review of Subjective Cognitive Impairment trials Research Report on Subjective Cognitive Impairment

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of a Multidomain Intervention Plus Turmeric on the Prevention of Cognitive Decline in People Over 55 Years of Age With Insulin Resistance.
Turmeric extract, Control: Placebo. 500mg gelatin in capsules 2 times a day - Cognitive Decline, Subjective Cognitive Impairment
Phase 2 / Phase 3Active not recruitingInstituto Mexicano del Seguro Social1002025-02-202026-03-25
Investigation of Memantine in the Treatment of Memory, Concentration or Attention Problems
Memantine, Placebo - Memory Disorder, Retention Disorder, Cognitive
Phase 2CompletedMerz Pharmaceuticals GmbH2992010-11-012013-11-27

Narrower conditions

Cognitive Dysfunction (1)  ·  Insulin Resistance (1)  ·  Memory Disorders (1)

Broader conditions

Cognition Disorders (1)  ·  Glucose Metabolism Disorders (1)  ·  Hyperinsulinism (1)  ·  Mental Disorders (1)  ·  Metabolic Diseases (1)  ·  Nervous System Diseases (1)  ·  Neurobehavioral Manifestations (1)  ·  Neurocognitive Disorders (1)  ·  Neurologic Manifestations (1)  ·  Nutritional and Metabolic Diseases (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Signs and Symptoms (1)

Interventions

Gelatin (1)  ·  Memantine (1)  ·  turmeric extract (1)

Sponsors

Instituto Mexicano del Seguro Social (1)  ·  Merz Pharmaceuticals GmbH (1)

Countries

Germany (1)  ·  Mexico (1)  ·  United Kingdom (1)

Top investigators

Svetlana Dubrovna, PhD (1)